安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份

Core Viewpoint - Anxu Bio (688075.SH) announced that shareholder Ma Huaxiang plans to reduce his holdings by up to 1.2 million shares, representing no more than 0.94% of the company's total share capital due to personal funding needs [1] Summary by Category - Company Actions - Ma Huaxiang intends to reduce his shareholding through centralized bidding transactions [1] - The total number of shares to be sold is capped at 1.2 million [1] - Shareholder Information - The reduction in shareholding is attributed to Ma Huaxiang's personal financial requirements [1] - The percentage of total share capital affected by this reduction is 0.94% [1]